NORMOSANG

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Japan, Lithuania, Malta, Netherlands, Romania, South Africa, Spain, UK.

Active ingredients

The drug NORMOSANG contains one active pharmaceutical ingredient (API):

1	Hemin UNII 743LRP9S7N - HEMIN
	Hemin arginate is indicated for hepatic porphyria (intermittent acute porphyria, porphyria variegata and hereditary coproporphyria). Hemin, by contributing to the re-establishment of normal levels of haemoproteins and of respiratory pigments, corrects the biological disorders observed in patients with porphyria.
	Read more about Hemin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORMOSANG Concentrate for solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B06AB	Heme products	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents
Discover more medicines within B06AB

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1227653
ES	Centro de información online de medicamentos de la AEMPS	63116
FI	Lääkealan turvallisuus- ja kehittämiskeskus	101105
FR	Base de données publique des médicaments	65109937
GB	Medicines & Healthcare Products Regulatory Agency	95682
HR	Agencija za lijekove i medicinske proizvode	HR-H-963951477
JP	医薬品医療機器総合機構	6349400A1026
LT	Valstybinė vaistų kontrolės tarnyba	1022291
MT	Medicines Authority	MA135/00101
NL	Z-Index G-Standaard	14733269
NL	Z-Index G-Standaard, PRK	44482
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59828001
ZA	Health Products Regulatory Authority	Z/34/19